Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

BACKGROUND: The efficacy and safety of azithromycin in the treatment of COVID-19 remain uncertain. We assessed whether adding azithromycin to standard of care, which included hydroxychloroquine, would improve clinical outcomes of patients admitted to the hospital with severe COVID-19. METHODS: We di...

Descripción completa

Detalles Bibliográficos
Autores principales: Furtado, Remo H M, Berwanger, Otavio, Fonseca, Henrique A, Corrêa, Thiago D, Ferraz, Leonardo R, Lapa, Maura G, Zampieri, Fernando G, Veiga, Viviane C, Azevedo, Luciano C P, Rosa, Regis G, Lopes, Renato D, Avezum, Alvaro, Manoel, Airton L O, Piza, Felipe M T, Martins, Priscilla A, Lisboa, Thiago C, Pereira, Adriano J, Olivato, Guilherme B, Dantas, Vicente C S, Milan, Eveline P, Gebara, Otavio C E, Amazonas, Roberto B, Oliveira, Monalisa B, Soares, Ronaldo V P, Moia, Diogo D F, Piano, Luciana P A, Castilho, Kleber, Momesso, Roberta G R A P, Schettino, Guilherme P P, Rizzo, Luiz Vicente, Neto, Ary Serpa, Machado, Flávia R, Cavalcanti, Alexandre B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836431/
https://www.ncbi.nlm.nih.gov/pubmed/32896292
http://dx.doi.org/10.1016/S0140-6736(20)31862-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836431/
https://www.ncbi.nlm.nih.gov/pubmed/32896292
http://dx.doi.org/10.1016/S0140-6736(20)31862-6

Ejemplares similares